BOROSIL SCIENTIFIC Latest Share Price (BOROSCI)
TODAY IN ONE LINE
BOROSCI edged up 0.4% on light volume, in line with Nifty's 0.3% move.
With a market cap of ₹1,066.03 Cr., it trades at a P/E of 25.81. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
BOROSIL SCIENTIFIC flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 212.2% YoY
- ●High Promoter HoldingPromoters hold 68.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Promoter BuyingPromoters increased holdings by 0.19% QoQ
- ●Positive Free Cash FlowFCF has been positive for 2 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 6.4% YoY
- ●Poor Capital ReturnsLow ROE of 8.6%
Latest BOROSIL SCIENTIFIC News
What changed recently?
Recent events, corporate actions, and announcements.
BOROSIL SCIENTIFIC valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for BOROSIL SCIENTIFIC, framed against the sector median so the premium or discount is obvious at a glance.
BOROSIL SCIENTIFIC trades at a P/E of 25.81× and P/B of 2.52×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
BOROSIL SCIENTIFIC technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for BOROSIL SCIENTIFIC — derived from the latest tape, not yesterday's close.
BOROSIL SCIENTIFIC last traded at ₹120 with an intraday range of ₹120–₹121.19 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹120.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 123.17 | +3.17 | +2.64% |
| R3 | 121.98 | +1.98 | +1.65% |
| R2 | 121.59 | +1.59 | +1.32% |
| R1 | 120.79 | +0.79 | +0.66% |
| PIVOT | 120.40 | 0.40 | 0.33% |
| CURRENT | 120.00 | — | — |
| S1 | 119.60 | -0.40 | -0.33% |
| S2 | 119.21 | -0.79 | -0.66% |
| S3 | 118.41 | -1.59 | -1.32% |
| S4 | 117.22 | -2.78 | -2.31% |
BOROSCI is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹120–₹121
Trading Inside opening range
BOROSIL SCIENTIFIC financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for BOROSIL SCIENTIFIC — consolidated or standalone — with margins, YoY growth and key ratios inline.
BOROSIL SCIENTIFIC reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,066.03 Cr. and reported EPS of ₹4.85.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 438 | 467 ▲ 6.6% |
| Sales Growth YoY %Derived | — | 6.58% |
| Other Income | 8 | 10 ▲ 22.1% |
| Total Income | 446 | 477 ▲ 6.9% |
| 161 | 167 ▲ 3.3% | |
| Gross ProfitDerived | 277 | 301 ▲ 8.5% |
| Gross Margin %Derived | 63.17% | 64.30% |
| 224 | 238 ▲ 6.2% | |
| EBITDA (Operating Profit)Derived | 53 | 62 ▲ 18.3% |
| OPM %Derived | 11.99% | 13.31% |
| 20 | 12 ▼ 40.9% | |
| Profit Before Tax (PBT) | 40 | 43 ▲ 6.1% |
| 14 | 8 ▼ 39.5% | |
| Effective Tax %Derived | 33.84% | 19.29% |
| Total Profit for Period | 27 | 35 ▲ 29.4% |
| Less: Non-controlling Interests | -0 | -0 ▲ 59.8% |
| Net Profit (Owner's PAT)Derived | 27 | 35 ▲ 29.1% |
| Net Profit Margin %Derived | 6.11% | 7.41% |
| PAT Growth YoY %Derived | — | 29.14% |
| Earnings Per Share (EPS ₹) | 3.01 | 3.89 ▲ 29.2% |
| Diluted Shares Outstanding (Cr) | 9 | 9 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 85.9% |
| Total Expenses (incl. D&A & Interest) | 406 | 434 ▲ 6.9% |
| Material Cost % of RevenueDerived | 32.74% | 33.90% |
| Employee Cost % of RevenueDerived | 17.58% | 17.16% |
| Other Cost % of RevenueDerived | 33.60% | 33.83% |
| Interest Coverage (x)Derived | 22.08x | 38.08x |
| Period | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|
| Revenue from Operations | 438 | 467 ▲ 6.6% | |
| Sales Growth YoY %Derived | — | 6.58% | |
| Other Income | 8 | 10 ▲ 22.1% | |
| Total Income | 446 | 477 ▲ 6.9% | |
161 | 167 ▲ 3.3% | ||
| Gross ProfitDerived | 277 | 301 ▲ 8.5% | |
| Gross Margin %Derived | 63.17% | 64.30% | |
224 | 238 ▲ 6.2% | ||
| EBITDA (Operating Profit)Derived | 53 | 62 ▲ 18.3% | |
| OPM %Derived | 11.99% | 13.31% | |
20 | 12 ▼ 40.9% | ||
| Profit Before Tax (PBT) | 40 | 43 ▲ 6.1% | |
14 | 8 ▼ 39.5% | ||
| Effective Tax %Derived | 33.84% | 19.29% | |
| Total Profit for Period | 27 | 35 ▲ 29.4% | |
| Less: Non-controlling Interests | -0 | -0 ▲ 59.8% | |
| Net Profit (Owner's PAT)Derived | 27 | 35 ▲ 29.1% | |
| Net Profit Margin %Derived | 6.11% | 7.41% | |
| PAT Growth YoY %Derived | — | 29.14% | |
| Earnings Per Share (EPS ₹) | 3.01 | 3.89 ▲ 29.2% | |
| Diluted Shares Outstanding (Cr) | 9 | 9 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 85.9% | |
| Total Expenses (incl. D&A & Interest) | 406 | 434 ▲ 6.9% | |
| Material Cost % of RevenueDerived | 32.74% | 33.90% | |
| Employee Cost % of RevenueDerived | 17.58% | 17.16% | |
| Other Cost % of RevenueDerived | 33.60% | 33.83% | |
| Interest Coverage (x)Derived | 22.08x | 38.08x |
BOROSIL SCIENTIFIC segment analysis : revenue and profit mix.
Disclosed business segments at BOROSIL SCIENTIFIC with their share of revenue and profit, switchable between consolidated and standalone reporting.
BOROSIL SCIENTIFIC discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for BOROSIL SCIENTIFIC.
Our AI distills the core fundamental drivers supporting BOROSIL SCIENTIFIC, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
BOROSIL SCIENTIFIC's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Debt-to-equity ratio 0.0000x ensures exceptionally strong balance sheet stability
Promoter holding 68.27% signals strong long-term commitment and founder alignment
Operating margin 9.19% supports healthy profitability across core operations
ROCE 12.10% indicates efficient capital deployment in manufacturing assets
Established since 1962 with 60+ years operational history and brand recognition
Key Risks.
Latest quarterly EPS grew 213.8% YoY but from severely depressed base levels
Quarterly sales declined 7.89% YoY, indicating demand slowdown in core markets
Quarterly profit fell 55.30% YoY, raising significant earnings volatility concerns
ROE of 8.60% remains below industry benchmarks, limiting shareholder value creation
P/E ratio of 43.41x appears elevated relative to 10.6% TTM growth trajectory
Flip Conditions.
Valuation risk. a P/E above 34 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
BOROSIL SCIENTIFIC peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — BOROSIL SCIENTIFIC is highlighted for quick read-across.
Quick Compare
Peer Comparison
BOROSIL SCIENTIFIC chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for BOROSIL SCIENTIFIC — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
BOROSIL SCIENTIFIC delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for BOROSIL SCIENTIFIC over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in BOROSIL SCIENTIFIC stood at 62.3% of traded volume, against a 20-day average of 54.6%.
BOROSIL SCIENTIFIC announcements: results, concalls, ratings, M&A.
Filings BOROSIL SCIENTIFIC sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
BOROSIL SCIENTIFIC files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 58 documents below.
Copy of Newspaper Publication
Borosil Scientific Limited has informed the Exchange about Copy of Newspaper Advertisements about Electronic Dispatch of the Annual Report for FY…
General Updates
Borosil Scientific Limited has informed the Exchange about Letter Containing Web-Link Of The Annual Report For FY 2025-26
Shareholders meeting
Borosil Scientific Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026
Copy of Newspaper Publication
Borosil Scientific Limited has informed the Exchange about Copy of Newspaper Publication regarding the 35th Annual General Meeting of the Company
General Updates
Borosil Scientific Limited has informed the Exchange about the 35th Annual General Meeting of the Company scheduled to be held on Friday, September…
Investor decks & rating reports.
BOROSIL SCIENTIFIC dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue BOROSIL SCIENTIFIC has declared, sequenced by announce and record date.
BOROSIL SCIENTIFIC corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About BOROSIL SCIENTIFIC: business, sector, key facts.
What BOROSIL SCIENTIFIC does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
BOROSIL SCIENTIFIC operates in the Glass - Industrial industry under the Capital Goods sector, listed as NSE: BOROSCI, BSE: 544184.
Borosil Scientific Limited is a prominent manufacturer and supplier of laboratory glassware and related equipment, serving diverse scientific and industrial sectors. Their product portfolio caters to a wide range of applications, solidifying their position as a significant player in the scientific supply chain.
A core component of their business is the production and distribution of laboratory glassware and consumables. This includes a comprehensive selection of items essential for various laboratory procedures, such as beakers, flasks, test tubes, and other specialized glassware. They also provide filtration products and analytical vials, along with a variety of accessories crucial for efficient laboratory operations.
Beyond basic glassware, Borosil Scientific Limited offers a substantial range of laboratory equipment. This equipment caters to various scientific disciplines, including those in nutrition and environmental science, life sciences, and liquid handling. Their offerings extend to encompass advanced instruments and apparatus, supplementing their comprehensive supply of basic laboratory necessities.
The company also plays a significant role in the pharmaceutical industry by manufacturing primary packaging materials. This includes glass ampoules and tubular glass vials, essential for the safe containment and distribution of pharmaceutical products. This segment underscores their commitment to providing solutions across different stages of the pharmaceutical lifecycle.
Further expanding their reach into industrial applications, Borosil Scientific Limited produces process science products. These include lab reactors and industrial reactors, as well as lab and industrial rotary evaporators. These products are critical for research and development, as well as large-scale manufacturing processes in various industries.
In summary, Borosil Scientific Limited's business model encompasses a broad spectrum of laboratory and industrial supplies. Their diverse product portfolio, from basic glassware to advanced process equipment, caters to a wide range of clients across various scientific and industrial sectors. The company's long history, dating back to 1962, speaks to their enduring presence and success in the marketplace.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- BOROSIL RENEWABLES (BORORENEW) Share PricePeer
- SEJAL GLASS (SEJALLTD) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about BOROSIL SCIENTIFIC (BOROSCI).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of BOROSIL SCIENTIFIC (BOROSCI)?
The current share price of BOROSIL SCIENTIFIC (BOROSCI) is ₹120.00. Today, the stock has gained by ₹0.44 (0.37%), trading in a range of ₹120.00 to ₹121.19. The stock opened at ₹120.00 with a trading volume of 6,780 shares.
02Is BOROSIL SCIENTIFIC stock a good investment for long-term?
BOROSIL SCIENTIFIC can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,066.03 Cr., P/E ratio of 25.81, ROE of 8.6%, and ROCE of 8.91%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of BOROSIL SCIENTIFIC stock?
The 52-week high price of BOROSIL SCIENTIFIC (BOROSCI) is ₹180.80, while the 52-week low is ₹96.64. Currently trading at ₹120.00, the stock is 24.17% above its 52-week low and 33.63% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy BOROSIL SCIENTIFIC stock at the current price?
Whether to buy BOROSIL SCIENTIFIC stock at ₹120.00 depends on multiple factors. The stock is currently trading with a P/E ratio of 25.81 and P/B ratio of 2.52. Today's performance shows a gain of 0.37%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of BOROSIL SCIENTIFIC and when is the next dividend?
BOROSIL SCIENTIFIC offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹120.00, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of BOROSIL SCIENTIFIC?
BOROSIL SCIENTIFIC's key financial metrics include: P/E Ratio: 25.81, P/B Ratio: 2.52, ROE: 8.6%, ROCE: 8.91%, Dividend Yield: 0%, EPS: ₹4.85, Book Value: ₹49.63, and Debt-to-Equity: 0. The company's market cap stands at ₹1,066.03 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is BOROSIL SCIENTIFIC stock performing today in the market?
BOROSIL SCIENTIFIC stock opened at ₹120.00 and is currently trading at ₹120.00, showing a gain of ₹0.44 (0.37%). The intraday high is ₹121.19 and low is ₹120.00. The trading volume stands at 6,780 shares, indicating moderate market participation today.
08What is the P/E ratio of BOROSIL SCIENTIFIC and what does it indicate?
BOROSIL SCIENTIFIC has a Price-to-Earnings (P/E) ratio of 25.81, which means investors are willing to pay 25.81 for every ₹1 of earnings. With an EPS of ₹4.85, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about BOROSIL SCIENTIFIC (BOROSCI) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.